Neuroendocrine effects of dexmedetomidine: Evidence of cross-tolerance between a μ-opioid agonist and an α2-adrenoceptor agonist in growth hormone secretion of the male rat

Pharmacology and Toxicology

Volumn 78, Issue 3, 1996, Pages 136-142

  Idanpaan Heikkila, Juhana J ^a   Rauhala, Pekka ^a   Männistö, Pekka T ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; DEXMEDETOMIDINE; GROWTH HORMONE; MORPHINE; NALOXONE; OPIATE AGONIST; PRAZOSIN; PROLACTIN; THYROTROPIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; GROWTH HORMONE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT;

ANIMALIA;

EID: 0029869259     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00194.x     Document Type: Article

References (48)

1. Aghajanian, G. K.: Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 1978, 276, 186-188.
2. Ahtee, L., L. M. J. Attila, K. R. Carlson & H. Haikala: Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state. J. Pharmacol. Exp. Therap. 1989, 249, 303-310.
3. Al-Damluji, S.: Adrenergic control of the secretion of anterior pituitary hormones. Baillière's Clin. Endocrin. Metab. 1993, 7, 355-392.
4. 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: Reversal by cyclic adenosine 3′:5′-monophosphate analogues. J. Neurosci. 1985, 5, 2359-2364.
5. Baker, H. J., J. R. Lindsey & S. H. Weisbroth: Housing to control research variables. In: The laboratory rat. Eds.: H. J. Baker, J. R. Lindsey & S. H. Weisbroth. Academic Press, New York, 1979, p. 178.
6. Bartoletti, M., M. Gaiardi, C. Gubellini, A. Bacchi & M. Babbini: Cross-tolerance between morphine and clonidine: A study on motility in rats. Neuropharmacology 1989, 28, 1159-1162.
7. Bentley, G. A., S. H. Newton & J. Starr: Studies on the antinociceptive action of α-agonist drugs and their interactions with opioid mechanisms. Brit. J. Pharmacol. 1983, 79, 125-134.
8. Bertherat, J., M. T. Bluet-Pajot & J. Epelbaum: Neuroendocrine regulation of growth hormone. Eur. J. Endocrinol. 1995, 132, 12-24.
9. Bruni, J. F., D. Van Vugt, S. Marshall & J. Meites: Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci. 1977, 21, 461-466.
10. Chapman, I. M. & J. O. Willoghby: Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Neuroendocrinology 1993, 57, 912-920.
11. Collier, H. O. J.: Cellular site of opiate dependence. Nature 1980, 283, 625-626.
12. 2-adrenergic receptors in rat brain. Nature 1981, 291, 493-495.
13. Idänpään-Heikkilä, J. J., P. Rauhala & P. T. Männistö: μ-and δ-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats. Eur. J. Pharmacol. 1995, 284, 227-230.
14. Idänpään-Heikkilä, J. J., P. Rauhala, R. K. Tuominen, P. Tuomainen, N. Zolotov & P. T. Männistö: Morphine withdrawal alters anterior pituitary hormone secretion, brain endopeptidase activity and brain monoamine metabolism in the rat. Pharmacology & Toxicology 1996, 78, 129-135.
15. Ignar, D. M. & C. M. Kuhn: Effects of specific mu-opiate and kappa-opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. J. Pharmacol. Exp. Therap. 1990, 255, 1287-1295.
16. Jaffer, A., W. M. U. Daniels, V. A. Russel & J. J. F. Taljaard: The effect of medial forebrain bundle lesion on thyrotropin secretion in the rat. Neurochem. Res. 1991, 16, 577-581.
17. Jurcovicova, J., T. Le & L. Krulich: The parodox of alpha-2 adrenergic regulation of prolactin (prl) secretion. I. The prl-releasing action of the alpha-2 receptor agonists. Brain Res. Bull. 1989a, 23, 417-424.
18. Jurcovicova, J., T. Le & L. Krulich: The paradox of alpha-2 adrenergic regulation of prolactin (prl) secretion. II. The prl-releasing action of the alpha-2 receptor antagonists. Brain Res. Bull. 1989b, 23, 425-432.
19. Kalso, E. A., A. F. Sullivan, H. J. McQuay, A. H. Dickenson & B. P. Roques: Cross-tolerance between mu-opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat. J. Pharmacol. Exp. Therap. 1993, 265, 551-558.
20. 2-adrenoceptors in morphine-stimulated release of growth hormone. Neuroendocrinology 1991, 53, 516-522.
21. Koenig, J. I., M. A. Mayfield, S. M. McCann & L. Krulich: Differential role of the opioid μ and δ receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat. Life Sci. 1984, 34, 1829-1837.
22. Krulich, L., M. A. Mayfield, M. K. Steele, B. A. McMillien, S. M. McCann & J. I. Koenig: Differential effects of pharmacological manipulations of central alpha-1 and alpha-2 adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology 1982, 110, 796-804.
23. Kuhn, C. M. & M. B. Bartolome: Effect of chronic methadone administration on neuroendocrine function in young adult rats. J. Pharmacol. Exp. Therap. 1985, 234, 204-210.
24. Kuret, J. A. & F. Murad: Adenohypophyseal hormones and related substances. In: The pharmacological basis of therapeutics, 8th ed. Eds.: A. Goodman Gilman, T. W. Rall, A. S. Nies & P. Taylor. Pergamon Press, New York, 1990, pp. 1334-1360.
25. Lal, H. & S. Fielding: Clonidine in the treatment of narcotic addiction. Trends Pharmacol. Sci. 1983, 4, 70-71.
26. Männistö, P. T., S. A. Borisenko, P. Rauhala, P. Tuomainen & R. K. Tuominen: Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 349, 1-9.
27. Paalzow, G.: Development of tolerance to the analgesic effect of clonidine in rats, cross-tolerance to morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1978, 304, 1-4.
28. 2-adrenoceptor agonists. J. Neural Transm. 1988, 72, 1-9.
29. Rauhala, P., P. T. Männistö & R. K. Tuominen: Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat. J. Pharmacol. Exp. Therap. 1988, 246, 649-654.
30. Rauhala, P., R. K. Tuominen, P. Tuomainen, M. Toivonen, S. A. Borisenko & P. T. Männistö: Development of tolerance to the hormonal effects of morphine without changes in the brain aminergic functions in the rat. Neuropharmacology 1992, 31, 765-770.
31. Rauhala, P., J. J. Idänpään-Heikkilä, R. K. Tuominen & P. T. Männistö: N-Nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol. 1994, 259, 57-64.
32. Rauhala, P., J. J. Idänpään-Heikkilä, R. K. Tuominen & P. T. Männistö: Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat. Eur. J. Pharmacol. 1995, 285, 69-77.
33. 2-adrenoceptor antagonist. Eur. J. Pharmacol. 1988, 151, 35-42.
34. Silverstone, P. H., C. Done & T. Sharp: In vivo monoamine release during naloxone-precipitated morphine withdrawal. Neuroreport 1993, 4, 1043-1045.
35. 2-adrenoceptor number and function in brains of morphine-dependent rats. Eur. J. Pharmacol. 1989, 161, 111-119.
36. Solomon, R. E. & G. F. Gebhart: Intrathecal morphine and clonidine: Antinociceptive tolerance and cross-tolerance and effects on blood pressure. J. Pharmacol. Exp. Therap. 1988, 245, 444-454.
37. Spaulding, T. C., S. Fielding, J. J. Venafro & H. Lal: Antinociceptive activity of clondine and its potentiation of morphine analgesia. Eur. J. Pharmacol. 1979, 58, 19-25.
38. Spiegel, K., I. A. Kourides & G. W. Pasternak: Prolactin and growth hormone release by morphine in the rat: Different receptor mechanisms. Science 1982, 217, 745-747.
39. 2-Adrenoceptor modulation of nociception in rat spinal cord: Location, effects and interactions with morphine. Eur. J. Pharmacol. 1987, 138, 169-177.
40. 2 adrenergic antinociception in the rat spinal cord. Neurosci. Lett. 1992, 139, 65-68.
41. Tallarida, R. J. & R. B. Murray: Manual of pharmacological calculations with computer programs. Springer-Verlag, New York, 1987.
42. Tuomisto, J. & P. T. Männistö: Neurotransmitter regulation of anterior pituitary hormones. Pharmacol. Rev. 1985, 37, 249-332.
43. 2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 336, 530-537.
44. Van Wimersma Greidanus, T. B. & A. B. Grossman: Opioid regulation of pituitary function. Progr. Sens. Physiol. 1991, 12, 1-64.
45. Vargas, M. L., M. L. Gonzalvez, J. A. Martinez, L. Arias, A. J. Bruger & M. V. Milanés: Effects of clonidine on pituitary-adrenocortical axis in morphine-tolerant rats and after naloxone-induced withdrawal. Pharmacology 1992, 44, 158-164.
46. 2-adrenoceptor agonist. Eur. J. Pharmacol. 1988, 150, 9-14.
47. Virtanen, R.: Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta vet. scand. 1989, 85, 29-37.
48. 2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther. 1989, 297, 190-204.